About
Alchemab Therapeutics develops antibody therapeutics by analyzing immune responses in resilient individuals, using AI and adaptive immunity to create treatments for hard-to-treat diseases such as cancer.
Explore Alchemab Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.